Cargando…
Development of the First World Health Organization Lentiviral Vector Standard: Toward the Production Control and Standardization of Lentivirus-Based Gene Therapy Products
Gene therapy is a rapidly evolving field. So far, there have been >2,400 gene therapy products in clinical trials and four products on the market. A prerequisite for producing gene therapy products is ensuring their quality and safety. This requires appropriately controlled and standardized produ...
Autores principales: | Zhao, Yuan, Stepto, Hannah, Schneider, Christian K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628571/ https://www.ncbi.nlm.nih.gov/pubmed/28747142 http://dx.doi.org/10.1089/hgtb.2017.078 |
Ejemplares similares
-
Production of lentiviral vectors
por: Merten, Otto-Wilhelm, et al.
Publicado: (2016) -
Development of a replication-competent lentivirus assay for dendritic cell-targeting lentiviral vectors
por: Farley, Daniel C, et al.
Publicado: (2015) -
An Improved Protocol for the Production of Lentiviral Vectors
por: Brown, Logan Y., et al.
Publicado: (2020) -
Lentiviral standards to determine the sensitivity of assays that quantify lentiviral vector copy numbers and genomic insertion sites in cells
por: Corre, Guillaume, et al.
Publicado: (2022) -
The first World Health Organization International Standard for infliximab products: A step towards maintaining harmonized biological activity
por: Metcalfe, Clive, et al.
Publicado: (2018)